IFU, my expectations for Peregrine success are relatively modest. I have said if the SP exceeds $5, I will start to cash out.
When I read some of the scurrilous crap that the complainers post over and over again, I occasionally feel the need to balance their uber negativity with some uber optimism. I do this sparingly, but I confess the impulse overcomes me at times.
Last year I apparently feel prey to impulse and guestimated Sunrise results would come in sooner than possible. Mea culpa.
However, more than 18 months into the 24 month projected enrollment seems like an early look-in triggered by 33% eventing of these very sick patients is not more than a few months away at most. On Tuesday Peregrine may tell us otherwise, but as of now we can expect that first look-in soon.
Also the second look-in only requires 17% more eventing. And, with the Bavi arm patients also eventing at this later state of the trial, this small additional increment should happen only a few months after the first look-in.
So, whether anyone pro or con likes it or not, unless we hear the enrollment is behind expectations, Sunrise will speak in months, not years. If Sunrise does not produce irrefutably, positive results, look out below. If it does produce irrefutably, positive result, I think we longs will do just fine.
GTLA, especially Bavi-arm Sunrise patients,
Paul
Market Data 
Markets 
AI
